30.1.2015   

HR

Službeni list Europske unije

C 32/1


Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. prosinca 2014. do 31. prosinca 2014.

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))

(2015/C 032/01)

—   Izdavanje odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

INN (međunarodni nezaštićeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

5.12.2014.

Paliperidone Janssen

Paliperidon

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/14/971

Suspenzija s produljenim oslobađanjem za injekciju

N05AX13

9.12.2014.

8.12.2014.

Duloksetin Lilly

duloksetin

Eli Lilly Nederland B.V.

Grootslag 1-5, NL-3991 RA Houten, Nederland

EU/1/14/972

Želučanootporna tvrda kapsula

N06AX21

10.12.2014.

8.12.2014.

Moventig

naloksegol

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/962

Filmom obložena tableta

A06AH03

10.12.2014.

16.12.2014.

DUAVIVE

konjugirani estrogeni/bazedoksifen

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/14/960

Tableta s prilagođenim oslobađanjem

G03CX

18.12.2014.

16.12.2014.

Lynparza

Olaparib

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/959

Kapsula, tvrda

L01

18.12.2014.

19.12.2014.

Cyramza

ramucirumab

Eli Lilly Nederland B.V.

Grootslag 1-5, NL-3991 RA Houten, Nederland

EU/1/14/957

Koncentrat za otopinu za infuziju

L01XC

23.12.2014.

19.12.2014.

Rixubis

nonakog gama

Baxter Innovations GmbH

Industriestraße 67, A-1221 Wien, Österreich

EU/1/14/970

Prašak i otapalo za otopinu za injekciju

B02BD04

23.12.2014.

22.12.2014.

Scenesse

afamelanotid

Clinuvel UK Limited

c/o – Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom

EU/1/14/969

Implantant

D02BB02

29.12.2014.

—   Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

1.12.2014.

Desloratadine Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/11/732

3.12.2014.

1.12.2014.

Ibandronic Acid Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/10/642

3.12.2014.

1.12.2014.

Irbesartan Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/09/576

3.12.2014.

1.12.2014.

Optimark

Mallinckrodt Deutschland GmbH

Josef-Dietzgen-Strasse 1, D-53773 Hennef, Deutschland

EU/1/07/398

3.12.2014.

4.12.2014.

Menveo

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1, 53100 Siena, Italia

EU/1/10/614

9.12.2014.

4.12.2014.

Ratiograstim

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/444

8.12.2014.

4.12.2014.

Tevagrastim

Teva GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/445

8.12.2014.

5.12.2014.

Cystagon

Orphan Europe S.A.R.L.

Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France

EU/1/97/039

9.12.2014.

5.12.2014.

Erbitux

Merck KGaA

64271 Darmstadt, Deutschland

EU/1/04/281

9.12.2014.

5.12.2014.

Vectibix

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/07/423

9.12.2014.

11.12.2014.

Bronchitol

Pharmaxis Pharmaceuticals Limited

The Priory, Stomp Road, Burnham, Buckinghamshire SL1 7LW, United Kingdom

EU/1/12/760

15.12.2014.

11.12.2014.

Efavirenz Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/742

15.12.2014.

11.12.2014.

Eviplera

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/11/737

15.12.2014.

11.12.2014.

Levetiracetam ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/11/702

15.12.2014.

11.12.2014.

Removab

Neovii Biotech GmbH

Am Haag 6-7, 82166 Graefelfing, Deutschland

EU/1/09/512

15.12.2014.

15.12.2014.

Lantus

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/134

18.12.2014.

15.12.2014.

Lemtrada

Genzyme Therapeutics Ltd

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford OX4 2SU, United Kingdom

EU/1/13/869

17.12.2014.

15.12.2014.

Levetiracetam Actavis Group

Actavis Group PTC ehf.

Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland

EU/1/11/738

18.12.2014.

15.12.2014.

Mircera

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/07/400

18.12.2014.

15.12.2014.

Naglazyme

BioMarin Europe Ltd

164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

EU/1/05/324

17.12.2014.

15.12.2014.

Optisulin

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/133

18.12.2014.

15.12.2014.

Revestive

NPS Pharma Holdings Limited

Grand Canal House, 1 Grand Canal Street Upper, Dublin 4, Ireland

EU/1/12/787

17.12.2014.

15.12.2014.

Somatropin Biopartners

BioPartners GmbH

Kaiserpassage 11, D-72764 Reutlingen, Deutschland

EU/1/13/849

17.12.2014.

15.12.2014.

Tasigna

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/422

18.12.2014.

15.12.2014.

Xeloda

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/00/163

18.12.2014.

16.12.2014.

Afinitor

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/538

18.12.2014.

16.12.2014.

Brintellix

H. Lundbeck A/S

Ottiliavej 9, DK-2500 Valby, Danmark

EU/1/13/891

18.12.2014.

16.12.2014.

Cimzia

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/09/544

17.12.2014.

16.12.2014.

Fasturtec

Sanofi-Aventis groupe

54 rue La Boétie, F-75008 Paris, France

EU/1/00/170

18.12.2014.

16.12.2014.

Hizentra

CSL Behring GmbH

Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

EU/1/11/687

18.12.2014.

16.12.2014.

HyQvia

Baxter Innovations GmbH

Industriestraße 67, A-1221 Wien, Österreich

EU/1/13/840

18.12.2014.

16.12.2014.

Incivo

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/11/720

18.12.2014.

16.12.2014.

Lamivudine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/09/566

18.12.2014.

16.12.2014.

Levetiracetam Actavis

Actavis Group PTC ehf.

Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland

EU/1/11/713

18.12.2014.

16.12.2014.

Methylthioninium chloride Proveblue

Provepharm S.A.S.

22 Rue Marc Donadille, 13013 Marseille, France

EU/1/11/682

18.12.2014.

16.12.2014.

NULOJIX

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/11/694

18.12.2014.

16.12.2014.

Orphacol

Laboratoires CTRS

63 rue de l'Est, F-92100 Boulogne-Billancourt, France

EU/1/13/870

18.12.2014.

16.12.2014.

Paglitaz

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/721

18.12.2014.

16.12.2014.

Pioglitazone Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/12/757

18.12.2014.

16.12.2014.

Pioglitazone Teva Pharma

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/12/758

18.12.2014.

16.12.2014.

Remsima

Celltrion Healthcare Hungary Kft.

Árpád Fejedelem útja 26-28, H-1023 Budapest, Magyarország

EU/1/13/853

18.12.2014.

16.12.2014.

Ristaben

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/621

19.12.2014.

16.12.2014.

Ristfor

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/620

17.12.2014.

16.12.2014.

Stivarga

Bayer Pharma AG

D-13342 Berlin, Deutschland

EU/1/13/858

18.12.2014.

16.12.2014.

Ultibro Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/13/862

18.12.2014.

16.12.2014.

Ulunar Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/14/917

19.12.2014.

16.12.2014.

Votubia

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/11/710

18.12.2014.

16.12.2014.

Xoterna Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/13/863

18.12.2014.

16.12.2014.

Zelboraf

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/12/751

19.12.2014.

19.12.2014.

CellCept

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/005

23.12.2014.

19.12.2014.

InductOs

Medtronic BioPharma B.V.

Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland

EU/1/02/226

23.12.2014.

19.12.2014.

Puregon

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/96/008

23.12.2014.

19.12.2014.

Rilutek

Aventis Pharma S.A.

20 avenue Raymond Aron, F-92165 Antony CEDEX, France

EU/1/96/010

23.12.2014.

19.12.2014.

Stayveer

Marklas Nederland B.V.

Beneluxlaan 2b, NL-3446 GR Woerden, Nederland

EU/1/13/832

5.1.2015.

19.12.2014.

Telmisartan Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/09/610

24.12.2014.

19.12.2014.

Travatan

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/01/199

23.12.2014.

19.12.2014.

Victoza

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/09/529

23.12.2014.

19.12.2014.

Zoledronic acid Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/771

24.12.2014.

19.12.2014.

Zoledronic acid Teva Pharma

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/772

24.12.2014.

—   Izdavanje odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

INN (međunarodni nezaštićeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

22.12.2014.

Bovela

Modificirani živi BVDV-1 necitopatogeni roditeljski soj KE-9, Modificirani živi BVDV-2 necitopatogeni roditeljski soj NY-93

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/2/14/176

Liofilizat i otapalo, suspenzija za injekciju

QI02AD02

29.12.2014.

—   Izmjena odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

4.12.2014.

Gripovac 3

Merial

29 avenue Tony Garnier, F-69007 Lyon, France

EU/2/09/102

8.12.2014.

4.12.2014.

Porcilis AR-T DF

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/00/026

8.12.2014.

4.12.2014.

Respiporc Flu3

IDT Biologika GmbH

Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland

EU/2/09/103

8.12.2014.

11.12.2014.

Comfortis

Eli Lilly and Company Ltd, Elanco Animal Health

Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom

EU/2/10/115

15.12.2014.

11.12.2014.

Trifexis

Eli Lilly and Company Ltd, Elanco Animal Health

Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom

EU/2/13/155

15.12.2014.

16.12.2014.

Pexion

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/12/147

18.12.2014.

Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

The European Medicines Agency

30, Churchill Place, Canary Wharf

UK – LONDON E14 5EU


(1)  SL L 136, 30.4.2004, str. 1.